Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 and cardiovascular disease in patients with chronic kidney disease.
Del Vecchio L, Balafa O, Dounousi E, Ekart R, Fernandez BF, Mark PB, Sarafidis P, Valdivielso JM, Ferro CJ, Mallamaci F. Del Vecchio L, et al. Among authors: balafa o. Nephrol Dial Transplant. 2024 Jan 31;39(2):177-189. doi: 10.1093/ndt/gfad170. Nephrol Dial Transplant. 2024. PMID: 37771078 Free PMC article. Review.
Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease.
Ortiz A, Ferro CJ, Balafa O, Burnier M, Ekart R, Halimi JM, Kreutz R, Mark PB, Persu A, Rossignol P, Ruilope LM, Schmieder RE, Valdivielso JM, Del Vecchio L, Zoccali C, Mallamaci F, Sarafidis P; European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney Working Group of the European Society of Hypertension (ESH). Ortiz A, et al. Among authors: balafa o. Nephrol Dial Transplant. 2023 Jan 23;38(1):10-25. doi: 10.1093/ndt/gfab167. Nephrol Dial Transplant. 2023. PMID: 33944938 Free article.
SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA.
Mark PB, Sarafidis P, Ekart R, Ferro CJ, Balafa O, Fernandez-Fernandez B, Herrington WG, Rossignol P, Del Vecchio L, Valdivielso JM, Mallamaci F, Ortiz A, Nistor I, Cozzolino M. Mark PB, et al. Among authors: balafa o. Nephrol Dial Transplant. 2023 Oct 31;38(11):2444-2455. doi: 10.1093/ndt/gfad112. Nephrol Dial Transplant. 2023. PMID: 37230946 Free PMC article. Review.
A randomized multicenter trial on a lung ultrasound-guided treatment strategy in patients on chronic hemodialysis with high cardiovascular risk.
Zoccali C, Torino C, Mallamaci F, Sarafidis P, Papagianni A, Ekart R, Hojs R, Klinger M, Letachowicz K, Fliser D, Seiler-Mußler S, Lizzi F, Wiecek A, Miskiewicz A, Siamopoulos K, Balafa O, Slotki I, Shavit L, Stavroulopoulos A, Covic A, Siriopol D, Massy ZA, Seidowsky A, Battaglia Y, Martinez-Castelao A, Polo-Torcal C, Coudert-Krier MJ, Rossignol P, Fiaccadori E, Regolisti G, Hannedouche T, Bachelet T, Jager KJ, Dekker FW, Tripepi R, Tripepi G, Gargani L, Sicari R, Picano E, London GM. Zoccali C, et al. Among authors: balafa o. Kidney Int. 2021 Dec;100(6):1325-1333. doi: 10.1016/j.kint.2021.07.024. Epub 2021 Aug 19. Kidney Int. 2021. PMID: 34418415 Clinical Trial.
Treatment-resistant hypertension in the hemodialysis population: a 44-h ambulatory blood pressure monitoring-based study.
Mallamaci F, Torino C, Sarafidis P, Ekart R, Loutradis C, Siamopoulos K, Del Giudice A, Aucella F, Morosetti M, Raptis V, Bikos A, Papagianni A, Balafa O, Pappas E, Tripepi R, Marino C, Tripepi G, Ferro C, Malyszko J, Dekker FW, Jager KJ, London GM, Zoccali C. Mallamaci F, et al. Among authors: balafa o. J Hypertens. 2020 Sep;38(9):1849-1856. doi: 10.1097/HJH.0000000000002448. J Hypertens. 2020. PMID: 32649620
63 results